- Home
- FGEN vs RAND Comparison
FGEN vs RAND Comparison
Compare FGEN & RAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FGEN
- RAND
- Stock Information
- Founded
- FGEN 1993
- RAND 1969
- Country
- FGEN United States
- RAND United States
- Employees
- FGEN N/A
- RAND N/A
- Industry
- FGEN Biotechnology: Pharmaceutical Preparations
- RAND Finance: Consumer Services
- Sector
- FGEN Health Care
- RAND Finance
- Exchange
- FGEN Nasdaq
- RAND Nasdaq
- Market Cap
- FGEN 45.1M
- RAND 44.7M
- IPO Year
- FGEN 2014
- RAND N/A
- Fundamental
- Price
- FGEN $11.12
- RAND $13.71
- Analyst Decision
- FGEN Strong Buy
- RAND
- Analyst Count
- FGEN 2
- RAND 0
- Target Price
- FGEN $146.50
- RAND N/A
- AVG Volume (30 Days)
- FGEN 24.8K
- RAND 3.9K
- Earning Date
- FGEN 11-03-2025
- RAND 11-07-2025
- Dividend Yield
- FGEN N/A
- RAND 12.19%
- EPS Growth
- FGEN N/A
- RAND N/A
- EPS
- FGEN N/A
- RAND N/A
- Revenue
- FGEN $7,346,000.00
- RAND $7,966,118.00
- Revenue This Year
- FGEN N/A
- RAND N/A
- Revenue Next Year
- FGEN N/A
- RAND N/A
- P/E Ratio
- FGEN N/A
- RAND N/A
- Revenue Growth
- FGEN N/A
- RAND 1.16
- 52 Week Low
- FGEN $4.50
- RAND $13.50
- 52 Week High
- FGEN $21.94
- RAND $31.89
- Technical
- Relative Strength Index (RSI)
- FGEN 50.35
- RAND 42.05
- Support Level
- FGEN $10.59
- RAND $13.55
- Resistance Level
- FGEN $11.22
- RAND $13.99
- Average True Range (ATR)
- FGEN 0.52
- RAND 0.35
- MACD
- FGEN -0.00
- RAND 0.03
- Stochastic Oscillator
- FGEN 58.60
- RAND 20.71
About FGEN FibroGen Inc
FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates. Geographically, it operates in United States, Japan, Europe and Others.
About RAND Rand Capital Corporation
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. The company's investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.